Cite
MLA Citation
David F. McDermott et al.. “Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma.” Journal of clinical oncology, vol. 39, no. 9, 2021, pp. 1020–1028. http://access.bl.uk/ark:/81055/vdc_100168590130.0x000012